These emerging therapies , Tirzepatide , represent a groundbreaking advancement in addressing type 2 diabetes and conceivably other conditions . These drugs are categorized as GLP-1 hormone activators , indicating they to emulate the endogenous GLP-1 peptide, enhancing metabolic production and lowering hunger . Although Tirzepatide each one operate